I agree - the safety profile of Trof once approved will (should) form a basis of new approvals so a phase 3 you would think would suffice fir new indications.
- Forums
- ASX - By Stock
- NEU
- Ann: Investor presentation, 8 August 2022
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.68%
!
$17.43

Ann: Investor presentation, 8 August 2022, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.43 |
Change
-0.120(0.68%) |
Mkt cap ! $2.207B |
Open | High | Low | Value | Volume |
$17.83 | $17.99 | $17.41 | $7.167M | 405.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 516 | $17.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.43 | 3 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 357 | 17.520 |
7 | 1443 | 17.510 |
17 | 18714 | 17.500 |
6 | 7032 | 17.490 |
4 | 279 | 17.480 |
Price($) | Vol. | No. |
---|---|---|
17.540 | 304 | 7 |
17.550 | 659 | 4 |
17.560 | 1143 | 7 |
17.570 | 826 | 7 |
17.580 | 801 | 4 |
Last trade - 12.08pm 08/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |